Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »

2/370 von 416 DIMDI: MEDLINE (ME60) © NLM

ND: | ME08493195
PMID: | 8493195
LR: | 20051116
CED: | 19930611
DCO: | 19930611
Autoren: | Spencer-Green G
Titel: | Drug treatment of arthritis. Update on conventional and less conventional methods.
Quelle: | Postgraduate medicine; VOL: 93 (7); p. 129-40 /19930515/
PM: | Print
SU: | AIM IM
Sprache: | English
CY: | UNITED STATES
JID: | 0401147
ISSN: | 0032-5481
CO: | POMDAS
Institution: | Dartmouth-Hitchcock Medical Center, Lebanon, NH 03756.
DT: | Journal Article; Review
RN: | 28
Schlagwörter
CT: | ADRENAL CORTEX HORMONES/therapeutic use; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL/pharmacology; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL/*therapeutic use; ARTHRITIS, RHEUMATOID/*drug therapy; AUROTHIOGLUCOSE/therapeutic use; AZATHIOPRINE/therapeutic use; GLUCOSAMINE/analogs & derivatives; GLUCOSAMINE/therapeutic use; GOLD SODIUM THIOMALATE/therapeutic use; HUMANS; HYDROXYCHLOROQUINE/therapeutic use; METHOTREXATE/therapeutic use; OSTEOARTHRITIS/*drug therapy
CTG: | NEBENNIERENRINDENHORMONE/therapeutische Anwendung; ANTIPHLOGISTIKA, NICHTSTEROIDALE/Pharmakologie; ANTIPHLOGISTIKA, NICHTSTEROIDALE/*therapeutische Anwendung; ARTHRITIS, RHEUMATOIDE/*Arzneimitteltherapie; GOLDTHIOGLUCOSE/therapeutische Anwendung; AZATHIOPRIN/therapeutische Anwendung; GLUCOSAMIN/Analoge & Derivate; GLUCOSAMIN/therapeutische Anwendung; NATRIUMGOLDTHIOMALAT/therapeutische Anwendung; MENSCH; HYDROXYCHLOROQUIN/therapeutische Anwendung; METHOTREXAT/therapeutische Anwendung; OSTEOARTHROSE/*Arzneimitteltherapie
TE: | Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Hydroxychloroquine/118-42-3; Aurothioglucose/12192-57-3; Gold Sodium Thiomalate/12244-57-4; Glucosamine/3416-24-8; Azathioprine/446-86-6; amiprilose/56824-20-5; Methotrexate/59-05-2
CR: | 118-42-3; 12192-57-3; 12244-57-4; 3416-24-8; 446-86-6; 56824-20-5; 59-05-2
AB: | Nonsteroidal anti-inflammatory drugs comprise an important class of medications that reduce the signs and symptoms of osteoarthritis and rheumatoid arthritis. They bring relief to millions of people but do not eliminate underlying disease. Disease-modifying antirheumatic drugs also bring relief, but these drugs are often ineffective and not well tolerated. Failure to provide long-term benefits combined with the high toxicity of most of the disease-modifying agents has prompted a search for more effective treatments. New methods using modern technologies have generated much enthusiasm and hold promise for the future. In the meantime, administration of nonsteroidal anti-inflammatory drugs and judicious use of disease-modifying agents remain the cornerstone of therapy for arthritis.

» Volltext »
» Fenster schließen »